We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 25

Supreme Court reins in state-action immunity doctrine

  • Reed Smith LLP
  • -
  • USA
  • -
  • February 20 2013

Yesterday, in FTC v. Phoebe Putney Health Systems, Inc., the Supreme Court rejected an expansive view of the state-action immunity doctrine

FTC's proposed rule changes modify HSR reporting requirements for pharmaceutical exclusive licensing deals

  • Reed Smith LLP
  • -
  • USA
  • -
  • August 15 2012

The Federal Trade Commission (“FTC”) is seeking public comment on proposed changes to the premerger notification rules to clarify when the transfer of exclusive marketing, sales and manufacturing rights to a patented pharmaceutical product requires notification to the agencies under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (15 U.S.C. 18a) (“HSR Act”

China Pharmaceutical Group loses bid to toss vitamin C case (China Daily 2012-07- 20) --- July 20, 2012

  • Reed Smith LLP
  • -
  • China
  • -
  • August 8 2012

China Pharmaceutical Group Ltd, Weisheng Pharmaceutical Co., Hebei Welcome Pharmaceutical Co., North China Pharmaceutical Group and Northeast Pharmaceutical Group, have lost their bid for dismissal of antitrust claims in a vitamin C price-fixing lawsuit

Congressional health policy hearings & markups

  • Reed Smith LLP
  • -
  • USA
  • -
  • November 11 2011

A number of Congressional committees have held hearings recently on health policy issues

FTC workshop on ACO policy scheduled for May 9

  • Reed Smith LLP
  • -
  • USA
  • -
  • May 3 2011

On May 9, 2011, the FTC is hosting a workshop to seek input on its "Proposed Statement of Antitrust Enforcement Policy," which discusses how the federal antitrust agencies will enforce U.S. antitrust laws when competing health care providers create new Accountable Care Organizations (ACOs) under the Affordable Care Act

Proposed Statement of Antitrust Enforcement Policy regarding Accountable Care Organizations

  • Reed Smith LLP
  • -
  • USA
  • -
  • April 12 2011

On March 31, 2011, the Federal Trade Commission (FTC) and Department of Justice (DOJ) issued a joint proposed Statement of Enforcement Policy to explain how the agencies intend to enforce U.S. antitrust laws with respect to Accountable Care Organizations (ACOs) - groups of health care providers that will be collaborating under the Patient Protection and Affordable Care Act

House approves health care antitrust act

  • Reed Smith LLP
  • -
  • USA
  • -
  • February 26 2010

On February 24, 2010, the House of Representatives approved H.R. 4626, the “Health Insurance Industry Fair Competition Act,” by a vote of 406 to 19

FTC report on drug company "pay-for-delay" agreements

  • Reed Smith LLP
  • -
  • USA
  • -
  • January 27 2010

The Federal Trade Commission has released a "staff study" entitled "Pay for Delay: How Drug Company Pay-Offs Cost Consumers Billions."

House panel approves bill to end insurance antitrust protections

  • Reed Smith LLP
  • -
  • USA
  • -
  • October 30 2009

The House Judiciary Committee has passed H.R. 3596, the Health Insurance Industry Antitrust Enforcement Act of 2009

FTC challenges proposed and completed acquisitions in the health care industry

  • Reed Smith LLP
  • -
  • USA
  • -
  • September 18 2009

The Federal Trade Commission ("FTC") has challenged some proposed and completed acquisitions of interest this summer, three of which have resulted in the abandonment of the proposed mergers

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy